| Chaitanya Pant, MD | |
|
1726 Shawano Ave, Green Bay, WI 54303-3216 | |
| (920) 496-4700 | |
| Not Available |
| Full Name | Chaitanya Pant |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 18 Years |
| Location | 1726 Shawano Ave, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639389984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 04-36304 (Kansas) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 67374-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Hospital Medical Center | Green bay, WI | Hospital |
| St Vincent Hospital | Green bay, WI | Hospital |
| Door County Medical Center | Sturgeon bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...
Rice University bioengineers have created a hydrogel that instantly turns from liquid to semisolid at close to body temperature - and then degrades at precisely the right pace.
National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH's advisory board voted to create the new center, Science's "Science Insider" blog reports (Kaiser, 12/7).
› Verified 5 days ago
| Entity Name | St Clare Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851477913 PECOS PAC ID: 0446211395 Enrollment ID: O20041023000037 |
News Archive
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...
Rice University bioengineers have created a hydrogel that instantly turns from liquid to semisolid at close to body temperature - and then degrades at precisely the right pace.
National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH's advisory board voted to create the new center, Science's "Science Insider" blog reports (Kaiser, 12/7).
› Verified 5 days ago
| Entity Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423 |
News Archive
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...
Rice University bioengineers have created a hydrogel that instantly turns from liquid to semisolid at close to body temperature - and then degrades at precisely the right pace.
National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH's advisory board voted to create the new center, Science's "Science Insider" blog reports (Kaiser, 12/7).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chaitanya Pant, MD Prevea Health, Po Box 19070, Green Bay, WI 54307-9070 Ph: (920) 496-4700 | Chaitanya Pant, MD 1726 Shawano Ave, Green Bay, WI 54303-3216 Ph: (920) 496-4700 |
News Archive
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.
Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...
Rice University bioengineers have created a hydrogel that instantly turns from liquid to semisolid at close to body temperature - and then degrades at precisely the right pace.
National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH's advisory board voted to create the new center, Science's "Science Insider" blog reports (Kaiser, 12/7).
› Verified 5 days ago
Amritha Chandrahasa Karkera, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-8000 | |
Yaw D Berko, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1726 Shawano Ave, Green Bay, WI 54303 Phone: 920-496-4700 | |
Lee James Klemens, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 835 S Van Buren St, Green Bay, WI 54301 Phone: 920-496-4700 Fax: 920-496-4705 | |
Dr. Kevin L Mortara, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1580 Commanche Ave, Green Bay, WI 54313 Phone: 920-435-8326 Fax: 920-430-4659 | |
William T Witmer, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd Ste 310, Green Bay, WI 54311 Phone: 920-288-8300 Fax: 920-288-8305 | |
Jay Matthew Salmon, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-8100 | |
Dr. Alay Mansurov, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1580 Commanche Ave, Green Bay, WI 54313 Phone: 920-435-8326 Fax: 920-430-4659 |